Sharon Hashmueli

Title: Sharon Hashmueli: Innovator in Plant Biotechnology

Introduction

Sharon Hashmueli is a prominent inventor based in Ramot-Naftali, Israel. She has made significant contributions to the field of plant biotechnology, particularly in the production of glycosylated proteins. With a total of 7 patents to her name, her work focuses on innovative methods for producing therapeutic proteins using transgenic plant systems.

Latest Patents

Hashmueli's latest patents include groundbreaking inventions such as a device, system, and method for producing glycosylated proteins in plant culture. This technology specifically targets proteins with high mannose glycosylation, utilizing an endoplasmic reticulum (ER) signal and bypassing the Golgi apparatus. Her inventions also encompass vectors and methods for the expression and production of enzymatically active high mannose lysosomal enzymes, particularly using transgenic carrot cells. Furthermore, her work provides compositions and methods for treating lysosomal storage diseases, showcasing her commitment to addressing critical health challenges.

Career Highlights

Sharon Hashmueli is currently associated with Protalix Ltd., where she continues to advance her research in plant biotechnology. Her innovative approaches have positioned her as a leader in the field, contributing to the development of therapeutic solutions that leverage plant systems for protein production.

Collaborations

Throughout her career, Hashmueli has collaborated with notable colleagues, including Yoseph Shaaltiel and Gideon Baum. These partnerships have enhanced her research efforts and expanded the impact of her inventions in the scientific community.

Conclusion

Sharon Hashmueli's work in plant biotechnology exemplifies the potential of innovative approaches to address complex medical challenges. Her contributions through her patents and collaborations continue to pave the way for advancements in therapeutic protein production.